{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"GT60","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"The response rate of bortezomib in combination with dexamethasone after 4 cycles was much higher than originally assumed. Therefore the sample size of the randomized groups is too small for further statistical analysis."},"pointOfContact":{"organization":"Janssen-Cilag Germany","phone":"+49 2137 955-492","title":"EMEA Medical Affairs Director Oncology"}}